ARTICLE | Product Development
A more rational antibody platform
How MorphoSys built Ylanthia antibody platform to replace HuCAL
January 30, 2012 8:00 AM UTC
With technology gained from its 2010 acquisition of Sloning BioTechnology GmbH, MorphoSys AG started from scratch to create Ylanthia, a new antibody library that will launch this year to replace the company's aging HuCAL platform.
MorphoSys was built on the success of HuCAL, an antibody phage display platform that launched in 1997. The platform has produced 77 programs in active development, 19 of which are in clinical testing...